Commerzbank Aktiengesellschaft FI bought a new stake in Humana Inc (NYSE:HUM) in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 1,321 shares of the insurance provider’s stock, valued at approximately $322,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Skandinaviska Enskilda Banken AB publ raised its stake in shares of Humana by 4.0% during the 3rd quarter. Skandinaviska Enskilda Banken AB publ now owns 25,974 shares of the insurance provider’s stock worth $6,328,000 after buying an additional 1,000 shares in the last quarter. KBC Group NV increased its stake in Humana by 75.1% in the 3rd quarter. KBC Group NV now owns 164,266 shares of the insurance provider’s stock valued at $40,020,000 after purchasing an additional 70,449 shares in the last quarter. Hartford Investment Management Co. increased its stake in Humana by 1.1% in the 3rd quarter. Hartford Investment Management Co. now owns 39,528 shares of the insurance provider’s stock valued at $9,630,000 after purchasing an additional 425 shares in the last quarter. Hillsdale Investment Management Inc. increased its stake in Humana by 18.9% in the 3rd quarter. Hillsdale Investment Management Inc. now owns 1,890 shares of the insurance provider’s stock valued at $461,000 after purchasing an additional 300 shares in the last quarter. Finally, Tiedemann Wealth Management LLC increased its stake in Humana by 18.1% in the 3rd quarter. Tiedemann Wealth Management LLC now owns 2,608 shares of the insurance provider’s stock valued at $241,000 after purchasing an additional 400 shares in the last quarter. 94.19% of the stock is owned by hedge funds and other institutional investors.

Several equities analysts recently weighed in on HUM shares. ValuEngine raised Humana from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $273.00 target price on the stock in a report on Tuesday, October 3rd. BidaskClub upgraded Humana from a “sell” rating to a “hold” rating in a report on Wednesday, August 23rd. Jefferies Group reiterated a “hold” rating and set a $257.00 target price on shares of Humana in a report on Friday, October 13th. Finally, Royal Bank of Canada reiterated a “hold” rating and set a $245.00 target price on shares of Humana in a report on Tuesday, October 10th. Twelve research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $255.80.

Shares of Humana Inc (NYSE HUM) traded down $3.46 during trading on Tuesday, reaching $253.03. The company had a trading volume of 947,200 shares, compared to its average volume of 1,379,130. Humana Inc has a 52-week low of $186.25 and a 52-week high of $264.56. The firm has a market capitalization of $36,642.18, a PE ratio of 21.89, a P/E/G ratio of 1.76 and a beta of 0.88. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.35.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.27 by $0.12. Humana had a return on equity of 15.99% and a net margin of 3.49%. The firm had revenue of $13.28 billion for the quarter, compared to analysts’ expectations of $13.41 billion. During the same quarter last year, the firm earned $3.18 earnings per share. The firm’s revenue for the quarter was down 3.0% compared to the same quarter last year. analysts predict that Humana Inc will post 11.63 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.63%. The ex-dividend date of this dividend is Thursday, December 28th. Humana’s payout ratio is currently 12.59%.

TRADEMARK VIOLATION WARNING: This piece was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was copied illegally and reposted in violation of international trademark and copyright laws. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/12/12/commerzbank-aktiengesellschaft-fi-buys-shares-of-1321-humana-inc-hum.html.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Stock Ratings for Humana Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc and related stocks with our FREE daily email newsletter.